Across TCGA pan-cancer cohorts, NOL4L-DT Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NOL4L-DT data layer compared with 12 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher NOL4L-DT Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated NOL4L-DT expression acts as an unfavorable survival marker.

ACC are the cancer types where NOL4L-DT Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.068	0.674	<.001	31	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: NOL4L-DT tumor-vs-normal RNA expression · all NOL4L-DT data types